2ND-LINE DRUG-THERAPY FOR RHEUMATOID-ARTHRITIS

被引：0

作者：

CASH, JM

KLIPPEL, JH

机构：

[1] NIAMS, ARTHRITIS & RHEUMATISM BRANCH, BETHESDA, MD 20892 USA

[2] CLEVELAND CLIN FDN, DEPT RHEUMAT & IMMUNOL DIS, CLEVELAND, OH 44195 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1994年 / 330卷 / 19期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1368 / 1375

页数：8

共 50 条

[1] COMBINATION 2ND-LINE THERAPY FOR RHEUMATOID-ARTHRITIS
WILLIAMS, HJ
[J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (07): : 603 - 604
[2] THE EFFECT OF ORDER OF 2ND-LINE DRUG-THERAPY ON THE DEVELOPMENT OF SIDE-EFFECTS IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA)
STEVEN, MM
HUNTER, JA
MURDOCH, RM
MCLAREN, A
CAPELL, HA
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (02) : 204 - 205
[3] 2ND-LINE AGENTS FOR RHEUMATOID-ARTHRITIS
SCHARF, SL
CHRISTOPHIDIS, N
[J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 163 (04) : 215 - 218
[4] LONG-TERM 2ND-LINE THERAPY IN RHEUMATOID-ARTHRITIS
BIRD, HA
[J]. CLINICAL RHEUMATOLOGY, 1985, 4 (02) : 121 - 123
[5] SELECTION OF SUITABLE PATIENTS FOR 2ND-LINE THERAPY IN RHEUMATOID-ARTHRITIS
PULLAR, T
CAPELL, HA
[J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 (03): : 276 - 281
[6] PRODUCTION OF INTERLEUKIN-6 BY MONOCYTES ISOLATED FROM RHEUMATOID-ARTHRITIS PATIENTS RECEIVING 2ND-LINE DRUG-THERAPY
CRILLY, A
MADHOK, R
WATSON, J
CAPELL, HA
STURROCK, RD
[J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (09): : 821 - 825
[7] DRUG-THERAPY AND RHEUMATOID-ARTHRITIS
CAPELL, HA
PULLAR, T
[J]. SCOTTISH MEDICAL JOURNAL, 1985, 30 (03) : 137 - 138
[8] DRUG-THERAPY FOR RHEUMATOID-ARTHRITIS
HATHAWAY, DE
[J]. MINNESOTA MEDICINE, 1985, 68 (08) : 593 - 594
[9] DOES 2ND-LINE THERAPY AFFECT THE RADIOLOGICAL PROGRESSION OF RHEUMATOID-ARTHRITIS
PULLAR, T
HUNTER, JA
CAPELL, HA
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1984, 43 (01) : 18 - 23
[10] DRUG-THERAPY IN RHEUMATOID-ARTHRITIS
GIBSON, T
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (13): : 856 - 856

← 1 2 3 4 5 →